…
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Philip Morris International is a global tobacco company operating outside the United States that sells cigarettes and is shifting toward heated tobacco and other reduced‑risk nicotine products. Long-term growth drivers include adoption of smoke‑free alternatives, pricing power in many markets and cash generation that could support dividends and capital returns, which may appeal to income-focused investors.
Key risks are regulatory and litigation pressure, higher excise taxes and slower-than-expected adoption of reduced‑risk products, any of which could depress volumes and margins.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 14585.00M | 12199.00M | 10607.00M | 11634.00M | 12232.00M |
| Minority interest | -500.00M | -446.00M | -455.00M | 479.00M | 601.00M |
| Net income | 11348.00M | 7034.00M | 7791.00M | 9048.00M | 9109.00M |
| Selling general administrative | 11752.00M | 11147.00M | 10060.00M | 8138.00M | 8419.00M |
| Selling and marketing expenses | - | - | 506.00M | - | 8304.00M |
| Gross profit | 27282.00M | 24549.00M | 22281.00M | 20360.00M | 21375.00M |
| Reconciled depreciation | 1996.00M | 1787.00M | 1398.00M | 1189.00M | 96.00M |
| Ebit | 15467.00M | 13962.00M | 11976.00M | 12246.00M | 12975.00M |
| Ebitda | 17463.00M | 15749.00M | 13374.00M | 12222.00M | 12956.00M |
| Depreciation and amortization | 1996.00M | 1787.00M | 1398.00M | -24.00M | -19.00M |
| Operating income | 14933.00M | 13402.00M | 11556.00M | 12246.00M | 12975.00M |
| Other operating expenses | 25715.00M | 24476.00M | 23618.00M | 19540.00M | 18545.00M |
| Interest expense | 1587.00M | 1763.00M | 1526.00M | 588.00M | 628.00M |
| Tax provision | 2737.00M | 3017.00M | 2339.00M | 2244.00M | 2671.00M |
| Interest income | 621.00M | 620.00M | 465.00M | 588.00M | 628.00M |
| Net interest income | -966.00M | -1143.00M | -1061.00M | -588.00M | -628.00M |
| Extraordinary items | 0.00M | -2316.00M | - | - | - |
| Income tax expense | 2737.00M | 2380.00M | 2339.00M | 2244.00M | 2671.00M |
| Total revenue | 40648.00M | 37878.00M | 35174.00M | 31762.00M | 31405.00M |
| Total operating expenses | 12349.00M | 11147.00M | 10725.00M | 8138.00M | 8515.00M |
| Cost of revenue | 13366.00M | 13329.00M | 12893.00M | 11402.00M | 10030.00M |
| Total other income expense net | -348.00M | -1203.00M | -949.00M | -612.00M | -743.00M |
| Net income from continuing ops | 11848.00M | 9819.00M | 8268.00M | 9390.00M | 9561.00M |
| Net income applicable to common shares | 11316.00M | 7034.00M | 7791.00M | 9048.00M | 9083.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 69185.00M | 61784.00M | 65304.00M | 61681.00M | 41290.00M |
| Intangible assets | 10884.00M | 11327.00M | 9864.00M | 6732.00M | 2818.00M |
| Other current assets | 2203.00M | 1826.00M | 1530.00M | 16412.00M | 13221.00M |
| Total liab | 77213.00M | 71654.00M | 74750.00M | 67992.00M | 49498.00M |
| Total stockholder equity | -9994.00M | -11750.00M | -11225.00M | -8957.00M | -10106.00M |
| Deferred long term liab | - | - | - | 1956.00M | 726.00M |
| Other current liab | 17319.00M | 15007.00M | 6902.00M | 15012.00M | 16232.00M |
| Common stock | 0.00M | 0.00M | 0.00M | 0.00M | -10106.00M |
| Capital stock | 0.00M | 0.00M | 0.00M | 0.00M | 0.00M |
| Retained earnings | 35400.00M | 32869.00M | 34090.00M | 34289.00M | 33082.00M |
| Other liab | - | - | - | 5345.00M | 5460.00M |
| Good will | 17264.00M | 16600.00M | 16779.00M | 19655.00M | 6680.00M |
| Other assets | 679.00M | 585.00M | 5830.00M | 17301.00M | 21128.00M |
| Cash | 4872.00M | 4216.00M | 3060.00M | 3207.00M | 4496.00M |
| Cash and equivalents | 4872.00M | 4216.00M | 3060.00M | 3207.00M | 4496.00M |
| Total current liabilities | 25427.00M | 22915.00M | 26383.00M | 27336.00M | 19255.00M |
| Current deferred revenue | - | - | - | - | -3331.00M |
| Net debt | 43963.00M | 41479.00M | 44849.00M | 39916.00M | 23310.00M |
| Short term debt | 3701.00M | 3529.00M | 6666.00M | 8248.00M | 3023.00M |
| Short long term debt | 3701.00M | 3529.00M | 6666.00M | 8248.00M | 3023.00M |
| Short long term debt total | 48835.00M | 45695.00M | 47909.00M | 43123.00M | 27806.00M |
| Other stockholder equity | -33098.00M | -33305.00M | -33500.00M | -33687.00M | -33611.00M |
| Property plant equipment | 9076.00M | 7895.00M | 8147.00M | 15443.00M | 6168.00M |
| Total current assets | 24363.00M | 20170.00M | 19755.00M | 19619.00M | 17717.00M |
| Long term investments | 2891.00M | 2654.00M | 4929.00M | 4431.00M | 4463.00M |
| Net tangible assets | - | - | - | -8957.00M | -10106.00M |
| Short term investments | - | - | 1.00M | - | - |
| Net receivables | 5810.00M | 4675.00M | 4391.00M | 4756.00M | 3940.00M |
| Long term debt | 45134.00M | 42166.00M | 41243.00M | 34855.00M | 24783.00M |
| Inventory | 11478.00M | 9453.00M | 10774.00M | 9886.00M | 8720.00M |
| Accounts payable | 4407.00M | 3952.00M | 4143.00M | 4076.00M | 3331.00M |
| Noncontrolling interest in consolidated entity | - | - | - | 2646.00M | 1898.00M |
| Accumulated other comprehensive income | -12296.00M | -11314.00M | -11815.00M | -9559.00M | -9577.00M |
| Retained earnings total equity | - | - | - | 34289.00M | 33082.00M |
| Treasury stock | - | - | - | -35917.00M | -35836.00M |
| Non currrent assets other | 4139.00M | 2783.00M | 5647.00M | 3931.00M | 2549.00M |
| Non current assets total | 44822.00M | 41614.00M | 45549.00M | 42062.00M | 23573.00M |
| Long term debt total | 45134.00M | 42166.00M | 41243.00M | 34875.00M | 24783.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -86.00M | -1092.00M | -3598.00M | 264.00M | 432.00M |
| Change to liabilities | - | - | - | 2320.00M | 1016.00M |
| Total cashflows from investing activities | -4488.00M | -1092.00M | -3598.00M | -15679.00M | -2358.00M |
| Net borrowings | 1706.00M | -1623.00M | 3702.00M | 14176.00M | -3042.00M |
| Total cash from financing activities | -7611.00M | -9481.00M | -5582.00M | 3806.00M | -11977.00M |
| Change to operating activities | - | - | - | 1862.00M | 623.00M |
| Net income | 11316.00M | 7503.00M | 8268.00M | 9527.00M | 9710.00M |
| Change in cash | 638.00M | 1108.00M | -71.00M | -1283.00M | -2785.00M |
| Begin period cash flow | 4254.00M | 3146.00M | 3217.00M | 4500.00M | 7285.00M |
| End period cash flow | 4892.00M | 4254.00M | 3146.00M | 3217.00M | 4500.00M |
| Total cash from operating activities | 12233.00M | 12217.00M | 9204.00M | 10803.00M | 11967.00M |
| Depreciation | 1996.00M | 1787.00M | 1398.00M | 1189.00M | 998.00M |
| Other cashflows from investing activities | -2279.00M | 297.00M | -2166.00M | -14866.00M | -2042.00M |
| Dividends paid | 8624.00M | 8197.00M | 7964.00M | -7812.00M | -7580.00M |
| Change to inventory | -1201.00M | 552.00M | -862.00M | -1287.00M | 549.00M |
| Change to account receivables | -448.00M | -738.00M | 314.00M | -871.00M | -198.00M |
| Sale purchase of stock | - | 0.00M | 0.00M | -209.00M | -775.00M |
| Other cashflows from financing activities | -693.00M | 339.00M | -1320.00M | 19346.00M | -580.00M |
| Change to netincome | - | - | - | -327.00M | -308.00M |
| Capital expenditures | 1569.00M | 1444.00M | 1321.00M | 1077.00M | 748.00M |
| Change receivables | - | - | - | -871.00M | -198.00M |
| Cash flows other operating | - | - | - | 252.00M | 200.00M |
| Cash and cash equivalents changes | - | - | - | -1070.00M | -2368.00M |
| Change in working capital | -1105.00M | 677.00M | -1300.00M | 162.00M | 1367.00M |
| Stock based compensation | - | - | 212.00M | - | -22.00M |
| Other non cash items | 873.00M | 2373.00M | 1168.00M | 159.00M | -69.00M |
| Free cash flow | 10664.00M | 10773.00M | 7883.00M | 9726.00M | 11219.00M |
Sector: Consumer Defensive Industry: Tobacco
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| PM Philip Morris International Inc |
-9.78 4.63% |
201.50 | 26.74 | 21.28 | 7.11 | 1318.70 | 8.15 | 18.53 |
| BTI British American Tobacco p.l.c. |
0.11 0.17% |
63.08 | 11.67 | 11.10 | 4.63 | 1.84 | 4.79 | 8.62 |
| BTAFF British American Tobacco p.l.c |
- -% |
61.07 | - | 7.91 | 3.31 | 1.20 | 3.79 | 10.29 |
| JAPAF Japan Tobacco Inc |
- -% |
46.50 | 19.83 | 15.62 | 0.02 | 2.71 | 3.36 | 9.96 |
| MO Altria Group |
-0.43 0.55% |
77.58 | 8.24 | 8.09 | 3.47 | 27.30 | 4.61 | 7.77 |
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.
| Name | Title | Year Born |
|---|---|---|
| Mr. Andre Calantzopoulos | Exec. Chairman | 1958 |
| Mr. Jacek Olczak | CEO & Director | 1965 |
| Mr. Emmanuel Babeau | Chief Financial Officer | 1967 |
| Mr. Frederic de Wilde | Pres of European Union Region | 1967 |
| Mr. Drago Azinovic | Pres of Middle East & Africa Region and PMI Duty Free | 1962 |
| Mr. Stefano Volpetti | Pres of Smoke-Free Products Category & Chief Consumer Officer | 1972 |
| Dr. Jorge Insuasty M.D. | Chief Life Sciences Officer | 1959 |
| Mr. Massimo Andolina | Sr. VP of Operations | 1969 |
| Mr. Frank De Rooij | VP of Treasury & Corp. Fin. | 1966 |
| Prof. Manuel C. Peitsch | Chief Science Officer | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.